Chase Investment Counsel’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9,012
Closed -$3.71M 135
2024
Q2
$3.71M Buy
9,012
+231
+3% +$91.5K 1.32% 28
2024
Q1
$3.55M Sell
8,781
-895
-9% -$315K 1.32% 25
2023
Q4
$2.96M Sell
9,676
-173
-2% -$46.7K 1.31% 24
2023
Q3
$2.38M Buy
9,849
+301
+3% +$77K 1.19% 35
2023
Q2
$2.29M Buy
+9,548
New +$1.98M 1.16% 37

Other funds holding MEDP

Chase Investment Counsel's MEDP Position: Q3 2024 in Review

Chase Investment Counsel sold out of Medpace (MEDP) in Q3 2024, closing a stake of 9,012 shares — an estimated $3.71M sold.

Chase Investment Counsel first reported a position in MEDP in Q2 2023 and held it in 5 quarters. The position peaked at $3.71M in Q2 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • Chase Investment Counsel reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • Chase Investment Counsel sold 9,012 Medpace shares in Q3 2024, an estimated $3.71M.
  • Chase Investment Counsel first reported a position in Medpace in Q2 2023 and held it in 5 quarters.
  • Chase Investment Counsel's Medpace position peaked at $3.71M in Q2 2024.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Chase Investment Counsel's 13F filing for Q3 2024, filed 5 Nov 2024.